Skip to Main Content

Neumora Therapeutics, Inc. Common Stock

NMRA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
NMRA Income Statement
NMRA Balance Sheet
NMRA Cash Flow

Recent trades of NMRA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
NMRA Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
NMRA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NMRA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by NMRA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Vasopressin receptor antagonists and products and methods related thereto Nov. 26, 2024
  • Patent Title: Multimodal dynamic attention fusion Sep. 10, 2024
  • Patent Title: Machine learning-based diagnostic classifier Jun. 04, 2024
  • Patent Title: Methods of treating neurological disorders May. 28, 2024
  • Patent Title: System and method for identifying transdiagnostic features shared across mental health disorders Mar. 26, 2024
  • Patent Title: Estimating uncertainty in predictions generated by machine learning models Jan. 30, 2024
  • Patent Title: Vasopressin receptor antagonists and products and methods related thereto Jan. 02, 2024
  • Patent Title: Systems and methods for screening, diagnosing, and stratifying patients Jan. 02, 2024
  • Patent Title: Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject Dec. 12, 2023
  • Patent Title: Machine learning systems for training encoder and decoder neural networks Oct. 24, 2023
  • Patent Title: Methods and systems for computer-generated predictive application of neuroimaging and gene expression mapping data Oct. 17, 2023
  • Patent Title: Machine learning systems for generating multi-modal data archetypes Aug. 29, 2023
  • Patent Title: Machine learning-based diagnostic classifier Aug. 01, 2023
  • Patent Title: Machine learning-based diagnostic classifier Jun. 13, 2023
  • Patent Title: Machine learning systems for processing multi-modal patient data Jun. 06, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of NMRA in WallStreetBets Daily Discussion

NMRA News

Recent insights relating to NMRA

CNBC Recommendations

Recent picks made for NMRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NMRA

NMRA Top Shareholders
Shareholder
Shares Held
NMRA Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NMRA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NMRA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top